左乙拉西坦联合地西泮治疗热惊厥患儿临床疗效研究

doi:10.3969/j.issn.1671-7171.2021.04.025

Abstract
Figure/Table
References (0)
Related Citation (15)

Download: PDF (1141 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract 【Objective】 To explore the curative effect of levetiracetam combined with diazepam in the treatment of children with febrile convulsion and the effect on serum Zeste gene enhancer homolog 2 (EZH2), neuron-specific enolase (NSE), S100β, neuron-specific growth factor (BDNF) level of influence.【Methods】 A total of 100 children with febrile convulsion admitted to our hospital from January 2018 to December 2019 were selected as the observation group, and 100 children in the same period from outpatient health examination were selected as the healthy control group. According to different treatment methods, the observation group was further divided into the group A (treated with diazepam, n=50) and the group B (treated with levetiracetam combined with diazepam, n=50).Serum EZH2, NSE, S100 β and BDNF levels were recorded and compared. 【Results】 The levels of serum EZH2, NSE, S100β and BDNF in the observation group were higher than those in the healthy control group (P<0.05). The drug onset time and seizure stopping time in the group A were (21.60±3.95) min and (24.51±4.06) min, respectively, while in the group B, they were (17.53±3.04) min and (20.48±3.77) min, respectively. The differences between the two groups were statistically significant (all P<0.05).Before treatment, the levels of serum EZH2, NSE, S100β and BDNF in both group A and B were not statistically significant (P>0.05). After treatment, the levels of serum EZH2, NSE and S100β in the group B were lower than those in the group A (P<0.05). The clinical effective rate of children in group B was 96% (48/50), which was higher than 92% (42/50) of children in group A; and the difference was statistically significant (Z=-2.198, P=0.028<0.05). 【Conclusion】 The serum EZH2, NSE, S100 β,and BDNF levels of febrile convulsion children were significantly higher than those of healthy children. The effect of levetiracetam combined with diazepam on febrile convulsion children was better than that of diazepam alone.

Key words： Seizures, Febrile/DT Piracetam/PD Diazepam/PD Child

Received: 26 October 2020

PACS:

R725

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors

Cite this article:

URL:

http://journal07.magtech.org.cn/yxlcyj/EN/10.3969/j.issn.1671-7171.2021.04.025 OR http://journal07.magtech.org.cn/yxlcyj/EN/Y2021/V38/I4/566

[1] 蒋颍,李国斌,赵莉萍,等.儿童热性惊厥的治疗进展及预后[J].海南医学,2019,30(5):655-658.
[2] 王燕梅,赵彦沙,杨银升,等.婴儿热性惊厥复发因素研究[J].中国药物与临床,2019,19(1):108-109.
[3] 丁鸿飞,朱香兰,章笑安,等.左乙拉西坦治疗小儿热性惊厥的效果及对血清神经元特异性烯醇化酶、S-100β蛋白表达的影响[J].中国医药导报,2019,16(36):119-122.
[4] 赵康容,韩田田,林琼,等.组蛋白甲基化修饰酶调节自噬的研究进展[J].江苏大学学报(医学版),2019,29(5):456-460.
[5] 杨智全,王海青,支更花, 等.外周血UCH-L1、NSE表达水平对热性惊厥患儿脑损伤及预后的评估价值[J].临床和实验医学杂志,2020,19(2):162-164.
[6] 王卫平,毛萌.儿科学[M].第8版.北京:人民卫生出版社,2013:400-402.
[7] 郭虎,郑帼.热性惊厥处理指南解读[J].实用儿科临床杂志,2011,3(6):85-86.
[8] CERISOLA A,CHAIBU＇N E,ROSAS M,et al. Febrile seizures:questions and answers[J].Medicina (B Aires),2018,78(S2):18-24.
[9] 刘科贝.高热惊厥小儿的临床特征及预后分析[J].实用临床医药杂志,2019,23(16):16-19.
[10] 徐健,孙明强,王媛媛,等.热性惊厥患儿血清中表观遗传标志物的表达及临床意义[J].中国现代医学杂志,2017,27(16):35-39.
[11] 徐健,孙明强,李锦亮, 等.热性惊厥患儿血清中DNA甲基转移酶的表达及其临床意义[J].中国医学前沿杂志(电子版),2018,10(1):50-52.
[12] 杨军,台晓燕.血清NSE、S100β和IL-6在早产儿脑损伤的临床应用[J].蚌埠医学院学报,2019,44(10):1362-1364,1369.
[13] 冯艳,江山,马进, 等.热性惊厥儿童血清BDNF水平及其与动态脑电图联合应用的价值[J].河北医科大学学报,2020,41(2):204-207,213.
[14] 王翠玲.热性惊厥的研究进展及合理用药[J].中国临床医生杂志,2017,45(3):18-21.
[15] 张艳君,杨国帅,刘炫君, 等.左乙拉西坦片与卡马西平片治疗难治性癫痫患者的临床研究[J].中国临床药理学杂志,2020,36(3):254-256.
[16] 林泽鸿,蔡晓莹,林广裕.地西泮与左乙拉西坦间歇短程治疗预防热性惊厥发作的研究进展[J].中国小儿急救医学,2018,25(1):56-60.